Modeling and Evaluation of Ash-Forming Element Fate and Occurrence in Woody Biomass Combustion in an Entrained-Flow Burner.

Biomass combustion equipment is often susceptible to ash deposition due to the relatively significant quantities of potassium, silicon, and other ash-forming elements in biomass. To evaluate the propensity for ash deposition resulting from biomass combustion, a biomass combustion model was integrated with a chemical equilibrium model to predict the fate and occurrence of ash-forming elements in a pilot-scale entrained-flow burner. The integrated model simulated the combustion of white wood (virgin wood) and recycled wood (treated wood) previously combusted in the burner. The key advantage of this model in comparison to a model with general equilibrium assumed is that it was able to consider the rate of release of trace and minor species with time, the local equilibrium in the particles, and separately, that in the continuum phase (which also included any solid or liquid materials nucleating). The simulation generated the fate and occurrence profiles of each ash-forming element along the burner. The qualitative comparisons between the modeled profiles and the previous experimental findings under similar operating conditions show reasonable agreement. The concentrations of ash-forming elements released from the burner were also compared with the experimental online inductively coupled plasma readings. However, the latter comparison shows overestimation using the modeled results and might suggest that further considerations of other parameters such as ash nucleation and coagulation are required. Nonetheless, based on the ongoing performance of the integrated model, future use of the model might be expanded to a broader range of problematic solid fuels such as herbaceous biomass or municipal solid waste.

Tolerance and dependence following chronic intracerebroventricular infusions of Tyr-D-Arg2-Phe-Sar4 (TAPS).

The dermorphin-derived tetrapeptide Tyr-D-Arg(2)-Phe-Sar(4) (TAPS) was tested for its ability to induce tolerance, cross-tolerance, withdrawal and its substitution properties in rats subjected to chronic intracerebroventricular (i.c.v.) infusions of mu-opiate receptor agonists. Tolerance and cross-tolerance were assessed by quantification of the thermally induced tail-flick response. Chronic intracerebroventricular infusion of TAPS resulted in antinociception at almost 1000-fold lower doses compared to morphine sulphate and [D-Ala(2), MePhe(4)Gly(ol)(5)]enkephalin (DAMGO). Tolerance to the antinociceptive effect of TAPS developed similar to DAMGO and morphine sulphate. Cross-tolerance to intracerebroventricular bolus injections of DAMGO, but not of TAPS, was evident in rats rendered tolerant to morphine sulphate and TAPS. Naloxone-induced withdrawal was equally pronounced in animals treated with morphine sulphate, DAMGO or TAPS. TAPS substituted for morphine sulphate and vice versa regarding the withdrawal syndrome in a cross-over experimental design. In contrast to DAMGO, TAPS retains its antinociceptive effect following bolus administration in rats rendered tolerant to mu-opioid receptor agonists.